Covid-19 roundup: Regeneron nabs priority review for mAb; Preprint suggests mixing boosters is safe ahead of adcomms
Nearly a year after being granted an EUA, Regeneron and Roche’s Covid-19 antibody cocktail will now go before the FDA for a chance at full …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
